NeuroScientific specialist hire sets stage for major Crohn’s trial
The Sydney Morning Herald - Oct 1, 2026
NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.